Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats.

Deabold KA, Schwark WS, Wolf L, Wakshlag JJ.

Animals (Basel). 2019 Oct 19;9(10). pii: E832. doi: 10.3390/ani9100832.

2.
3.

US Veterinarians' Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions.

Kogan L, Schoenfeld-Tacher R, Hellyer P, Rishniw M.

Front Vet Sci. 2019 Jan 10;5:338. doi: 10.3389/fvets.2018.00338. eCollection 2018.

4.

Pharmacokinetics of Bedrocan®, a cannabis oil extract, in fasting and fed dogs: An explorative study.

Łebkowska-Wieruszewska B, Stefanelli F, Chericoni S, Owen H, Poapolathep A, Lisowski A, Giorgi M.

Res Vet Sci. 2019 Apr;123:26-28. doi: 10.1016/j.rvsc.2018.12.003. Epub 2018 Dec 17.

PMID:
30580232
5.

Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs.

Gamble LJ, Boesch JM, Frye CW, Schwark WS, Mann S, Wolfe L, Brown H, Berthelsen ES, Wakshlag JJ.

Front Vet Sci. 2018 Jul 23;5:165. doi: 10.3389/fvets.2018.00165. eCollection 2018.

6.

Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs.

Bartner LR, McGrath S, Rao S, Hyatt LK, Wittenburg LA.

Can J Vet Res. 2018 Jul;82(3):178-183.

Supplemental Content

Loading ...
Support Center